Filing Details
- Accession Number:
- 0000950170-24-060613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-15 17:30:07
- Reporting Period:
- 2024-05-14
- Accepted Time:
- 2024-05-15 17:30:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840574 | Verve Therapeutics Inc. | VERV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573163 | D. Andrew Ashe | C/O Verve Therapeutics, Inc. 201 Brookline Avenue, Suite 601 Boston MA 02215 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-14 | 76,000 | $6.26 | 342,509 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $6.22 to $6.30 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
